Related Experiment Video
Updated: Jul 21, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Role of budesonide inhalation suspension in children with asthma
Kelly M West1, Nicole S Culhane
1Nesbitt School of Pharmacy, Wilkes University, Wilkes-Barre, PA 18766-0997, USA. sparano@wilkes.edu
Insights
Budesonide inhalation suspension (BIS) effectively treats pediatric asthma by reducing inflammation, improving lung function, and alleviating symptoms. This nebulized corticosteroid is a key option for children aged 1-8 with persistent asthma.
Area of Science:
- Pediatric Pulmonology
- Pharmacology
- Respiratory Medicine
Background:
- Asthma is a prevalent chronic inflammatory respiratory disease in children, affecting millions.
- Corticosteroids are foundational in asthma management by reducing airway inflammation.
- Effective delivery of medication is crucial for managing pediatric asthma symptoms.
Purpose of the Study:
- To assess the efficacy of budesonide inhalation suspension (BIS) for treating asthma in pediatric patients.
- To determine the role of BIS as a treatment option for children with persistent asthma.
- To evaluate BIS in comparison to other inhalation devices for pediatric asthma management.
Main Methods:
- A comprehensive literature search was conducted using Medline and article references.
- The search encompassed studies published from 1966 to November 2000.
- Keywords used were 'budesonide' and 'asthma' to identify relevant research.
Main Results:
- Budesonide inhalation suspension (BIS) is the first nebulized corticosteroid available for asthma treatment.
- BIS demonstrated effectiveness in reducing inflammation, a key factor in asthma.
- The study highlights the potential of BIS to improve lung function and decrease symptoms in children.
Conclusions:
- Budesonide inhalation suspension (BIS) is an effective treatment for reducing asthma symptoms and enhancing lung function in children.
- BIS is recommended for children aged 1-8 years experiencing moderate to severe persistent asthma.
- This therapy is particularly beneficial for pediatric patients who struggle with metered-dose inhalers or dry-powder inhalers.
Objective:
To evaluate the role of budesonide inhalation suspension (BIS) in the treatment of children with asthma.
Data Sources:
Literature identified through Medline (1966-November 2000) and references obtained from selected articles. Search terms included budesonide and asthma.
Data Synthesis:
Asthma is a chronic inflammatory disease that affects approximately 4.8 million children in the US. By reducing inflammation, corticosteroids decrease symptoms and improve lung function. As the first nebulized corticosteroid, BIS offers an important treatment option for children with persistent asthma.
Conclusions:
BIS is effective in reducing symptoms and improving lung function in children with asthma. It should be used in children ages 1-8 years with moderate to severe persistent asthma who are unable to effectively use a metered-dose inhaler with or without a spacer or a dry-powder inhaler.
More Related Videos
Related Concept Videos
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
COPD: Management Using Bronchodilators and Corticosteroids
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Inhaled Medications

